Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

Clinical trial NCT07006467 · RECRUITING

Trial details

NCT number: NCT07006467
Sponsor: Stentit
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Critical Limb Ischemia (CLI)

Start date: 2025-06-03
Primary completion: 2025-09-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.